Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-019483 General Corporate
Debt relative to revenue 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
131.66% · OPTIONAL · VALID
Capex intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.94% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.68% · OPTIONAL · VALID
Revenue growth 22th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
-5.40% · CORE · VALID
Inventory pressure 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
60.50% · OPTIONAL · VALID
Gross margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
20.33% · CORE · VALID
Operating margin 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
12.49% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.45% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.58% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 146.11%
Current 131.66%
Delta -14.46% Capex Intensity Increased
Previous 3.63%
Current 4.94%
Delta 1.31% Cash Generation Increased
Previous 5.39%
Current 15.68%
Delta 10.29% Growth Decreased
Previous -0.31%
Current -5.40%
Delta -5.09% Inventory Pressure Decreased
Previous 72.95%
Current 60.50%
Delta -12.45% Margin Increased
Previous 18.76%
Current 20.33%
Delta 1.57% Profitability Increased
Previous 10.88%
Current 12.49%
Delta 1.61% R And D Intensity Increased
Previous 1.35%
Current 1.45%
Delta 0.10% Sbc Intensity Decreased
Previous 0.62%
Current 0.58%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.